View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Amgen Inc. - September 2023 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

 PRESS RELEASE

Optinose to Present at the 35th Annual Piper Sandler Healthcare Confer...

Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference YARDLEY, Pa., Nov. 22, 2023 (GLOBE NEWSWIRE) -- (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the 35th Annual Piper Sandler Healthcare Conference on November 29, 2023, at 3:30 p.m. ET. To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website. A replay of the webcast will be available ...

Bristol Myers Squibb Co: 1 director

A director at Bristol Myers Squibb Co bought 8,500 shares at 49.810USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

 PRESS RELEASE

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussi...

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with David Denton, Chief Financial Officer, Executive Vice President, at the Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023 at 10:50 a.m. EST. To view and listen to the webcast, visit our web site at . Information on accessing and registering for the webcast will be available at beginning today. The transcript and webcast replay of the discussion will be made available on our web site at within 24 hours after the end of the live di...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

 PRESS RELEASE

Catalyst Pharmaceuticals To Participate in Piper Sandler 35th Annual H...

Catalyst Pharmaceuticals To Participate in Piper Sandler 35th Annual Healthcare Conference CORAL GABLES, Fla., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced that Patrick J. McEnany, Chairman and CEO of Catalyst, along with other members of the management team, will participate at the upcoming Piper Sandler 35th Annual Healthcare Conference taking place at the Lotte New Y...

Merck & Co Inc: 1 director

A director at Merck & Co Inc sold 43,823 shares at 105.029USD and the significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

 PRESS RELEASE

ProPhase Labs Announces Financial Results for the Three Months Ended S...

ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023 Company sees significant momentum in Pharmaloz, Nebula Genomics and ProPhase BioPharma Pharmaloz Manufacturing plans on track to increase capacity from $10 million to over $75 million in 2024 Indications of demand for entire planned capacity expansion Nebula Genomics opens new, state of the art Whole Genome Sequencing lab in Garden City, NY. Strong indications for demand lead to significant planned capacity expansion. Company to hold a conference call Thursday, November 9, 2023, at 11:00 A...

 PRESS RELEASE

Optinose Reports Third Quarter 2023 Financial Results and Operational...

Optinose Reports Third Quarter 2023 Financial Results and Operational Updates Company reports third quarter 2023 XHANCE net revenue of $19.8 million and increases full year 2023 XHANCE net revenue guidance Strong improvement in operating efficiency as SG&A and R&D expenses decreased by $32M or 33% year-to-date PDUFA goal date for XHANCE Chronic Rhinosinusitis sNDA is December 16, 2023 Conference call and webcast to be held today at 8:00 a.m. Eastern Time YARDLEY, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) --  Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by e...

Wedbush Research
  • Wedbush Research
 PRESS RELEASE

Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial R...

Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update      Third Quarter 2023 Total Net Revenues of $102.7 Million, a 79.4% Increase YOY Third Quarter 2023 GAAP Net Loss per Share of $(0.29) Diluted, Impacted by an $81.5 Million One Time Non-Recurring IPR&D Expense Related to the Acquisition of AGAMREE® License Third Quarter 2023 Non-GAAP Net Income of $55.9 Million, $0.49 per Share Diluted Reported U.S. FDA Approval of AGAMREE® (vamorolone) for Duchenne Muscular Dystrophy sNDA Seeking to Increase FIRDAPSE® Maximum Daily Dose to 100 mg...

Eli Lilly & Co: 1 director

Two Directors at Eli Lilly & Co bought/sold 685 shares at between 0.000USD and 571.100USD. The significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over t...

 PRESS RELEASE

Biogen Appoints Monish Patolawala to its Board of Directors

Biogen Appoints Monish Patolawala to its Board of Directors Accomplished executive brings deep expertise leading global financial organizations and overseeing successful business transformation CAMBRIDGE, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- (Nasdaq: BIIB) today announced the appointment of Monish Patolawala, currently President and Chief Financial Officer of 3M Company (“3M”), to the Company’s Board of Directors (the “Board”), effective January 1, 2024. As an accomplished financial executive, Mr. Patolawala is qualified as an Audit Committee financial expert and may be asked to se...

Wedbush Research
  • Wedbush Research
2454 MEDIA TEK INC
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
UDR UDR INC.
TSCO TRACTOR SUPPLY COMPANY
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SBUX STARBUCKS CORPORATION
SAGE SAGE THERAPEUTICS INC.
RGNX REGENXBIO INC.
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
MU MICRON TECHNOLOGY INC.
MNKD MANNKIND CORP.
MAA MID-AMERICA APARTMENT COMMUNITIES INC.
LOW LOWE'S COMPANIES INC.
INTC INTEL CORPORATION
HD HOME DEPOT INC.
FATE FATE THERAPEUTICS INC
ESS ESSEX PROPERTY TRUST INC.
EQR EQUITY RESIDENTIAL
CTMX CYTOMX THERAPEUTICS INC.
CPT CAMDEN PROPERTY TRUST
BIIB BIOGEN INC.
AVB AVALONBAY COMMUNITIES INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
FRX_CN FENNEC PHARMACEUTICALS
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
TAP MOLSON COORS BEVERAGE COMPANY CLASS B
HPE HEWLETT PACKARD ENTERPRISE CO.
CLSD CLEARSIDE BIOMEDICAL INC
FND FLOOR & DECOR HOLDINGS INC. CLASS A
MRSN MERSANA THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
RCUS ARCUS BIOSCIENCES
AVGO BROADCOM INC.
SRRK SCHOLAR ROCK HOLDING CORPORATION
LQDA LIQUIDIA CORPORATION
DELL DELL TECHNOLOGIES INC CLASS C
DDOG DATADOG INC CLASS A
SMCI SUPER MICRO COMPUTER
AQST INC.
TVTX AQUESTIVE THERAPEUTICS
AIRC TRAVERE THERAPEUTICS INC
ELEV APARTMENT INCOME REIT
MRVL ELEVATION ONCOLOGY
STX MARVELL TECHNOLOGY INC
VERA SEAGATE TECHNOLOGY HLDGS PLC
GFS VERA THERAPEUTICS INC
MLTX GLOBALFOUNDRIES INC
HR MOONLAKE IMMUNOTHERAPEUTICS
HEALTHCARE TRUST OF AMERICA INC.
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch